Cell type and culture condition-dependent alternative splicing in human breast cancer cells revealed by splicing-sensitive microarrays

Cancer Research

Volumn 66, Issue 4, 2006, Pages 1990-1999

  Li, Chunxia ^a   Kato, Mitsuo ^a   Shiue, Lily ^b   Shively, John E ^a   Ares Jr , Manuel ^b   Lin, Ren Jang ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; FAS ANTIGEN; HERMES ANTIGEN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; MESSENGER RNA PRECURSOR; PROTEIN APLP2; PROTEIN MYL6; PROTEIN RBM9; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; APLP2 GENE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CD44 GENE; CELL CULTURE; CELL TYPE; CONTROLLED STUDY; DNA MICROARRAY; FAS GENE; FEMALE; GENE; GENE EXPRESSION REGULATION; GEOMETRY; HNRNPA GENE; HNRNPB GENE; HUMAN; HUMAN CELL; METASTASIS; MICROARRAY ANALYSIS; MOUSE; MYL6 GENE; NONHUMAN; PRIORITY JOURNAL; RBM9 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THREE DIMENSIONAL IMAGING; XENOGRAFT;

ALTERNATIVE SPLICING; ANIMALS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; COLLAGEN; DISEASE PROGRESSION; DRUG COMBINATIONS; FEMALE; HUMANS; LAMININ; MICE; MICE, NUDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOGLYCANS; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS;

EID: 33644542406     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-2593     Document Type: Article

References (45)

1. Venables JP. Aberrant and alternative splicing in cancer. Cancer Res 2004;64:7647-54.
2. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
3. Orban TI, Olah E. Emerging roles of BRCA1 alternative splicing. Mol Pathol 2003;56:191-7.
4. Mazoyer S, Puget N, Perrin-Vidoz L, et al. A BRCA1 nonsense mutation causes exon skipping. Am J Hum Genet 1998;62:713-5.
5. Liu HX, Cartegni L, Zhang MQ, Krainer AR. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 2001;27:55-8.
6. Manley JL, Tacke R. SR proteins and splicing control. Genes Dev 1996;10:1569-79.
7. Hastings ML, Krainer AR. Pre-mRNA splicing in the new millennium. Curr Opin Cell Biol 2001;13:302-9.
8. Stickeler E, Kittrell F, Medina D, Berget SM. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 1999;18:3574-82.
9. Clark TA, Sugnet CW, Ares M, Jr. Genomewide analysis of mRNA processing in yeast using splicing-specific microarrays. Science 2002;296:907-10.
10. Yeakley JM, Fan JB, Doucet D, et al. Profiling alternative splicing on fiber-optic arrays. Nat Biotechnol 2002;20:353-8.
11. Johnson JM, Castle J, Garrett-Engele P, et al. Genomewide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003;302:2141-4.
12. Wang H, Hubbell E, Hu JS, et al. Gene structure-based splice variant deconvolution using a microarray platform. Bioinformatics 2003;19 Suppl 1:i315-22.
13. Le K, Mitsouras K, Roy M, et al. Detecting tissue-specific regulation of alternative splicing as a qualitative change in microarray data. Nucleic Acids Res 2004;32:e180.
14. Burckin T, Nagel R, Mandel-Gutfreund Y, et al. Exploring functional relationships between components of the gene expression machinery. Nat Struct Mol Biol 2005;12:175-82.
15. Blanchette M, Green RE, Brenner SE, Rio DC. Global analysis of positive and negative pre-mRNA splicing regulators in Drosophila. Genes Dev 2005;19:1306-14.
16. Pan Q, Shai O, Misquitta C, et al. Revealing global regulatory features of mammalian alternative splicing using a quantitative microarray platform. Mol Cell 2004;16:929-41.
17. Relogio A, Ben-Dov C, Baum M, et al. Alternative splicing microarrays reveal functional expression of neuron-specific regulators in Hodgkin lymphoma cells. J Biol Chem 2005;280:4779-84.
18. Mukhopadhyay R, Theriault RL, Price JE. Increased levels of α6 integrins are associated with the metastatic phenotype of human breast cancer cells. Clin Exp Metastasis 1999;17:325-32.
19. Shafie SM, Liotta LA. Formation of metastasis by human breast carcinoma cells (MCF-7) in nude mice. Cancer Lett 1980;11:81-7.
20. Srinivasan K, Shiue L, Hayes JD, et al. Detection and measurement of alternative splicing using splicing-sensitive microarrays. Methods 2005;37:345-59.
21. Naot D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res 1997;71:241-319.
22. Boutros R, Bailey AM, Wilson SH, Byrne JA. Alternative splicing as a mechanism for regulating 14-3-3 binding: interactions between hD53 (TPD52L1) and 14-3-3 proteins. J Mol Biol 2003;332:675-87.
23. Kleinman HK, McGarvey ML, Liotta LA, et al. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 1982;21:6188-93.
24. Wolf K, Mazo I, Leung H, et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 2003;160:267-77.
25. Sahai E, Marshall CJ. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 2003;5:711-9.
26. Cukierman E, Pankov R, Stevens DR, Yamada KM. Taking cell-matrix adhesions to the third dimension. Science 2001;294:1708-12.
27. Glondu M, Liaudet-Coopman E, Derocq D, et al. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells. Oncogene 2002;21:5127-34.
28. Kirshner J, Chen CJ, Liu P, Huang J, Shively JE. CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture. Proc Natl Acad Sci U S A 2003;100:521-6.
29. Suzuki T, Ando K, Isohara T, et al. Phosphorylation of Alzheimer β-amyloid precursor-like proteins. Biochemistry 1997;36:4643-9.
30. Adlerz L, Beckman M, Holback S, et al. Accumulation of the amyloid precursor-like protein APLP2 and reduction of APLP1 in retinoic acid-differentiated human neuroblastoma cells upon curcumin-induced neurite retraction. Brain Res Mol Brain Res 2003;119:62-72.
31. Sandbrink R, Masters CL, Beyreuther K. Similar alternative splicing of a non-homologous domain in β A4-arayloid protein precursor-like proteins. J Biol Chem 1994;269:14227-34.
32. Scott HS, Antonarakis SE, Lalioti MD, et al. Identification and characterization of two putative human arginine methyltransferases (HRMT1L1 and HRMT1L2). Genomics 1998;48:330-40.
33. Qi C, Chang J, Zhu Y, et al. Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor α. J Biol Chem 2002;277:28624-30.
34. Lev-Maor G, Sorek R, Shomron N, Ast G. The birth of an alternatively spliced exon: 3′ splice-site selection in Alu exons. Science 2003;300:1288-91.
35. Norris JD, Fan D, Sherk A, McDonnell DP. A negative coregulator for the human ER. Mol Endocrinol 2002;16:459-68.
36. Nakahata S, Kawamoto S. Tissue-dependent isoforms of mammalian Fox-1 homologs are associated with tissue-specific splicing activities. Nucleic Acids Res 2005;33:2078-89.
37. Screaton GR, Xu XN, Olsen AL, et al. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci U S A 1997;94:4615-9.
38. Grenet J, Valentine V, Kitson J, et al. Duplication of the DR3 gene on human chromosome 1p36 and its deletion in human neuroblastoma. Genomics 1998;49:385-93.
39. Ruberti G, Cascino I, Papoff G, Eramo A. Fas splicing variants and their effect on apoptosis. Adv Exp Med Biol 1996;406:125-34.
40. Iida N, Bourguignon LY. Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis. J Cell Physiol 1997;171:152-60.
41. Blaustein M, Pelisch F, Coso OA, et al. Mammary epithelial-mesenchymal interaction regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase. J Biol Chem 2004;279:21029-37.
42. Sgambato V, Minassian R, Nairn AC, Hyman SE. Regulation of ania-6 splice variants by distinct signaling pathways in striatal neurons. J Neurochem 2003;86:153-64.
43. Tchilian EZ, Beverley PC. CD45 in memory and disease. Arch Immunol Ther Exp (Warsz) 2002;50:85-93.
44. Lenz S, Lohse P, Seidel U, Arnold HH. The alkali light chains of human smooth and nonmuscle myosins are encoded by a single gene. Tissue-specific expression by alternative splicing pathways. J Biol Chem 1989;264:9009-15.
45. Zhu Y, Lin H, Wang M, et al. Up-regulation of transcription of smooth muscle myosin alkali light chain by ethanol in human breast cancer cells. Int J Oncol 2001;18:1299-305.